On Monday, June 6, another meeting of the Transparency Council.
AOTMiT: The Transparency Council will evaluate drugs, incl. for AD and acute lymphoblastic leukemia
Published May 31, 2022 08:15
Źródło: AOTMiT
The agenda includes:
Preparation of a position on the evaluation of Dupixent (dupilumabum) under the drug program: "Treatment of patients with severe form of atopic dermatitis (ICD-10: L20).
Preparation of an opinion on the reimbursement of drugs containing the active substance posaconazolum in the following indications:
• financed under the pharmacy list: acute lymphoblastic leukemia in children up to 18 years of age - secondary antifungal prophylaxis aimed at pre-existing fungal infections - until the end of chemotherapy; malignant lymphomas in children up to 18 years of age - secondary antifungal prophylaxis aimed at pre-existing fungal infections - until the end of chemotherapy; solid tumors in children up to 18 years of age - secondary antifungal prophylaxis aimed at pre-existing fungal infections - until the end of chemotherapy;
• financed under the chemotherapy catalog: standard or intermediate risk acute lymphoblastic leukemia - in children up to 18 years of age: - receiving chemotherapy that may cause long-term neutropenia and who are at high risk of developing invasive fungal infections, or - secondary antifungal prophylaxis targeting pre-existing fungal infections - until the end of chemotherapy; Malignant lymphomas - in children up to 18 years of age: - receiving chemotherapy that may cause long-term neutropenia and at high risk of developing invasive fungal infections or - secondary antifungal prophylaxis aimed at pre-existing fungal infections - until the end of chemotherapy; solid tumors - in children up to 18 years of age: - receiving chemotherapy that may cause long-term neutropenia and at high risk of developing invasive fungal infections or - secondary antifungal prophylaxis targeting pre-existing fungal infections - until the end of chemotherapy.
Preparation of opinions on draft health policy programs of local government units:
• "Early detection of colorectal neoplasms among the inhabitants of the city of Krosno in the years 2022-2023"
• "Early breast cancer detection program among female residents of Krosno for the years 2022-2023".
Source: AOTMiT
